Diabetes Digital Health brings together the multifaceted information surrounding the science of digital health from an academic, regulatory, industrial, investment and cybersecurity perspective. Clinicians and researchers who are developing and evaluating mobile apps for diabetes patients will find this essential reading, as will industry people whose companies are developing mobile apps and sensors.
- Provides valuable information for clinicians, researchers and industry about the design and evaluation of patient-facing diabetes adherence technologies
- Highlights cutting-edge topics that are presented and discussed at the Digital Diabetes Congress
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
1. Reducing the global burden of diabetes using mobile health
Mohan Deepa, Muralidharan Shruti and Viswanathan Mohan
2. Diabetes education reimagined: educator-led, technology-enabled diabetes population health management services
Sacha Uelmen and Janice MacLeod
3. Digital technologies to support behavior change: challenges and opportunities
Ashutosh Sabharwal, Sherecce Fields, Marisa E. Hilliard and Daniel J. DeSalvo
4. Agile science: what and how in digital diabetes research
Lyndsay A. Nelson, Anthony L. Threatt, William Martinez, S. Will Acuff and Lindsay S. Mayberry
5. Behavior change techniques for diabetes technologies
Connie Wong and Maureen Monaghan
6. Integrating behavior and context with glucose data to advance behavioral science and clinical care in diabetes
Claire J. Hoogendoorn, Dominic Ehrmann, Gladys Crespo-Ramos, Arielle G. Asman and Jeffrey S. Gonzalez
7. Designing human-centered user experiences and user interfaces
Erin Henkel, Jessica Randazza-Pade and Ben Healy
Section 2: Clinical aspects of digital health for diabetes
8. Using social media to support type 1 diabetes management and outcomes for adolescents and young adults: areas of promise and challenge
Elissa R. Weitzman and Lauren E. Wisk
9. Social media for adults
Elia Gabarron, Meghan Bradway and Eirik Arsand
10. Using diabetes technology in older adults
Nancy A. Allen and Michelle L. Litchman
11. Socioeconomic factors: access to and use of diabetes technologies
Samantha A. Barry-Menkhaus, David V. Wagner, Maggie Stoeckel and Michael A. Harris
12. The autonomous point-of-care diabetic retinopathy examination
Michael D. Abramoff
13. Digital foot care-leveraging digital health to extend ulcer-free days in remission
Bijan Najafi, Mark Swerdlow, Grant A. Murphy and David G. Armstrong
14. Smart insulin pens and devices to track insulin doses
David C. Klonoff, Victoria Hsiao, Hope Warshaw and David Kerr
Section 3: Technical aspects of digital health for diabetes
15. Research end points for diabetes digital health
Kathryn L. Fantasia, Mary-Catherine Stockman and Katherine L. Modzelewski
16. Digital health technologies, diabetes, and driving (meet your new backseat driver)
Andjela Drincic, Matthew Rizzo, Cyrus Desouza and Jennifer Merickel
17. Standards for digital health
Syed Umer Abdul Aziz, Mariam Askari and Shahid N. Shah
18. Are digital therapeutics poised to become mainstream in diabetes care?
Pablo Salazar and Adam Somauroo
19. The US Food and Drug Administration regulation of digital health
20. Cybersecurity of digital diabetes devices
Christine Sublett and William "Brad Marsh
Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association's 2019 Outstanding Physician Clinician Award. He has received an FDA Director's Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF.
Dr. David Kerr is Director of Research and Innovation at Sansum Diabetes Research Institute, Santa Barbara, and Director of Digital Services for the Diabetes Technology Society. Previously he was Consultant Physician in Internal Medicine and Endocrinology at the Bournemouth Diabetes and Endocrine Centre in the UK. His research and innovation continue to focus on the use of technology for diabetes care and also the new area of digital health. He is co-founder of the annual Digital Diabetes Congress and recently launched a major long-term initiative to reduce the burden of diabetes for an underserved population in the United States through the creation of an innovative long-term cohort study (Mil Familias). He is also lead investigator in a program exploring the value of food as medicine through the use of medical prescriptions of vegetables for adults with or at risk of type 2 diabetes (Farming for Life).
Mulvaney, Shelagh A.
Shelagh Mulvaney, PhD, is an Associate Professor and pediatric psychologist at Vanderbilt University. Her research focuses on integrating behavioral science into the design and evaluation of technology-mediated self-management support systems for adolescents and young adults with diabetes. Central to her research are technologies and processes that engage patients in their daily health behaviors including mobile technologies, social learning mechanisms, and self-care problem solving. A primary focus of her work is on momentary assessment of affect, cognition, and behavior for personalized feedback and health communications.